2021 International Congress on Myeloproliferative Neoplasms

 

2021 International Congress on Myeloproliferative Neoplasms
Avatar

Novel Agents of Potential Value in the MPN

By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Naveen Pemmaraju
By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Naveen Pemmaraju
13 views
December 15, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Videos
22:32

Hereditary Erythrocytosis

2021 International Congress on Myeloproliferative Neoplasms

M. McMullin

29 views
21:43

Clonal and Nonclonal Thrombocytosis

2021 International Congress on Myeloproliferative Neoplasms

J. Spivak

42 views
21:07

Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…

2021 International Congress on Myeloproliferative Neoplasms

J. Mascarenhas

14 views
22:50

JAK2V617F and Clonal Hematopoiesis

2021 International Congress on Myeloproliferative Neoplasms

A. Moliterno

24 views
21:36

MPN Stem Cell Fitness and the Link to Clinical Outcomes

2021 International Congress on Myeloproliferative Neoplasms

J. Scandura

23 views
23:26

Candidate Drugs for Preventing MPN Progression

2021 International Congress on Myeloproliferative Neoplasms

R. Hoffman

20 views
19:42

Hot Topics in Hypereosinophilic Syndrome

2021 International Congress on Myeloproliferative Neoplasms

A. Klion

143 views
17:39

Novel Agents of Potential Value in the MPN

2021 International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

13 views
15:12

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Ris…

2021 International Congress on Myeloproliferative Neoplasms

G. Abu-Zeinah

18 views
17:41

Exploiting Iron Metabolism to Treat Polycythemia Vera

2021 International Congress on Myeloproliferative Neoplasms

Y. Ginzburg

14 views
24:03

Inflammation in MPNs: Clinical and Therapeutic Aspects

2021 International Congress on Myeloproliferative Neoplasms

H. Hasselbalch

13 views
20:56

Treatment Approaches for Early MF

2021 International Congress on Myeloproliferative Neoplasms

R. Mesa

310 views
32:24

New ELN Recommendations for CML

2021 International Congress on Myeloproliferative Neoplasms

R. Hehlmann

126 views
17:46

Which Published Schemas Are Helpful in MPN Transplant Decisions?

2021 International Congress on Myeloproliferative Neoplasms

S. Giralt

12 views
22:47

Anticoagulant Management in the MPNs

2021 International Congress on Myeloproliferative Neoplasms

C. Kessler

19 views
20:00

Are Hematologists Rational?

2021 International Congress on Myeloproliferative Neoplasms

R. Gale

21 views
12:42

Pediatric MPNs: An Unfamiliar Topic

2021 International Congress on Myeloproliferative Neoplasms

N. Kucine

15 views
20:20

Role of NGS in the Diagnosis and Prognosis of MPNs

2021 International Congress on Myeloproliferative Neoplasms

A. Vannucchi

248 views
21:09

Update on the Clinical Status of Commonly Used Drugs in Primary MF

2021 International Congress on Myeloproliferative Neoplasms

S. Verstovsek

266 views